Matson DO (2006). «The pentavalent rotavirus vaccine, RotaTeq». Seminars in paediatric infectious diseases17 (4): 195–9. doi:10.1053/j.spid.2006.08.005. PMID17055370.
Widdowson MA, Steele D, Vojdani J, Wecker J, Parashar U (November 2009). «Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines». The Journal of Infectious Diseases200 Suppl 1: S1–8. doi:10.1086/605061. PMID19817589.
Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, Cortes JE, Lopman BA, Patel MM, Gentsch JR, Parashar UD (January 2011). «Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data». The Pediatric Infectious Disease Journal30 (1 Suppl): S56–60. doi:10.1097/INF.0b013e3181fefdc0. PMID21183842.
Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, Cortese MM, Nakagomi O, Cunliffe NA, Jiang B, Neuzil KM, de Oliveira LH, Glass RI, Parashar UD (April 2010). «Global impact of rotavirus vaccines». Expert Review of Vaccines9 (4): 395–407. doi:10.1586/erv.10.17. PMID20370550.
Soares-Weiser K, Maclehose H, Ben-Aharon I, Goldberg E, Pitan F, Cunliffe N (2010). «Vaccines for preventing rotavirus diarrhoea: vaccines in use». Cochrane Database Syst Rev (5): CD008521. doi:10.1002/14651858.CD008521. PMID20464766.
Parez N (March 2008). «Rotavirus gastroenteritis: why to back up the development of new vaccines?». Comparative Immunology, Microbiology and Infectious Diseases31 (2-3): 253–69. doi:10.1016/j.cimid.2007.07.005. PMID17698192.
drugs.com
«Rotavirus Vaccine Live Oral». The American Society of Health-System Pharmacists. Ανακτήθηκε στις 14 Δεκεμβρίου 2015.
Matson DO (2006). «The pentavalent rotavirus vaccine, RotaTeq». Seminars in paediatric infectious diseases17 (4): 195–9. doi:10.1053/j.spid.2006.08.005. PMID17055370.
Widdowson MA, Steele D, Vojdani J, Wecker J, Parashar U (November 2009). «Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines». The Journal of Infectious Diseases200 Suppl 1: S1–8. doi:10.1086/605061. PMID19817589.
Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, Cortes JE, Lopman BA, Patel MM, Gentsch JR, Parashar UD (January 2011). «Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data». The Pediatric Infectious Disease Journal30 (1 Suppl): S56–60. doi:10.1097/INF.0b013e3181fefdc0. PMID21183842.
Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, Cortese MM, Nakagomi O, Cunliffe NA, Jiang B, Neuzil KM, de Oliveira LH, Glass RI, Parashar UD (April 2010). «Global impact of rotavirus vaccines». Expert Review of Vaccines9 (4): 395–407. doi:10.1586/erv.10.17. PMID20370550.
Soares-Weiser K, Maclehose H, Ben-Aharon I, Goldberg E, Pitan F, Cunliffe N (2010). «Vaccines for preventing rotavirus diarrhoea: vaccines in use». Cochrane Database Syst Rev (5): CD008521. doi:10.1002/14651858.CD008521. PMID20464766.
Parez N (March 2008). «Rotavirus gastroenteritis: why to back up the development of new vaccines?». Comparative Immunology, Microbiology and Infectious Diseases31 (2-3): 253–69. doi:10.1016/j.cimid.2007.07.005. PMID17698192.
